Trifluoperazine-d3 (hydrochloride)

Modify Date: 2024-01-18 18:48:14

Trifluoperazine-d3 (hydrochloride) Structure
Trifluoperazine-d3 (hydrochloride) structure
Common Name Trifluoperazine-d3 (hydrochloride)
CAS Number 1432064-02-2 Molecular Weight 483.44
Density N/A Boiling Point N/A
Molecular Formula C21H23D3Cl2F3N3S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Trifluoperazine-d3 (hydrochloride)


Trifluoperazine-d3 (dihydrochloride) is deuterium labeled Trifluoperazine (dihydrochloride). Trifluoperazine dihydrochloride, an antipsychotic agent, acts by blocking central dopamine receptors. Trifluoperazine dihydrochloride is a potent α1-adrenergic receptor antagonist. Trifluoperazine dihydrochloride is a potent NUPR1 inhibitor exerting anticancer activity. Trifluoperazine dihydrochloride is a calmodulin inhibitor, and also inhibits P-glycoprotein. Trifluoperazine dihydrochloride can be used for the research of schizophrenia. Trifluoperazine dihydrochloride acts as a reversible inhibitor of influenza virus morphogenesis[1][2][3][4][5].

 Names

Name Trifluoperazine-d3 (hydrochloride)
Synonym More Synonyms

 Trifluoperazine-d3 (hydrochloride) Biological Activity

Description Trifluoperazine-d3 (dihydrochloride) is deuterium labeled Trifluoperazine (dihydrochloride). Trifluoperazine dihydrochloride, an antipsychotic agent, acts by blocking central dopamine receptors. Trifluoperazine dihydrochloride is a potent α1-adrenergic receptor antagonist. Trifluoperazine dihydrochloride is a potent NUPR1 inhibitor exerting anticancer activity. Trifluoperazine dihydrochloride is a calmodulin inhibitor, and also inhibits P-glycoprotein. Trifluoperazine dihydrochloride can be used for the research of schizophrenia. Trifluoperazine dihydrochloride acts as a reversible inhibitor of influenza virus morphogenesis[1][2][3][4][5].
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

[2]. Santofimia-Castaño P, et al. Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis. J Clin Invest. 2019;129(6):2500-2513. Published 2019 Mar 28.

[3]. Huerta-Bahena J, Villalobos-Molina R, García-Sáinz JA. Trifluoperazine and chlorpromazine antagonize alpha 1- but not alpha2- adrenergic effects. Mol Pharmacol. 1983;23(1):67-70.

[4]. Marques LO, Lima MS, Soares BG. Trifluoperazine for schizophrenia. Cochrane Database Syst Rev. 2004;2004(1):CD003545.

[5]. Howland RH. Trifluoperazine: A Sprightly Old Drug. J Psychosoc Nurs Ment Health Serv. 2016;54(1):20-22.

[6]. Ochiai H, et al. Influence of trifluoperazine on the late stage of influenza virus infection in MDCK cells. Antiviral Res. 1991;15(2):149-160.

 Chemical & Physical Properties

Molecular Formula C21H23D3Cl2F3N3S
Molecular Weight 483.44
Exact Mass 482.136475

 Synonyms

10-{3-[4-(2H3)Methyl-1-piperazinyl]propyl}-2-(trifluoromethyl)-10H-phenothiazine dihydrochloride
10H-Phenothiazine, 10-[3-[4-(methyl-d3)-1-piperazinyl]propyl]-2-(trifluoromethyl)-, hydrochloride (1:2)
Trifluoperazine-d3 (hydrochloride)